Latest News about BIIB
Recent news which mentions BIIB
Top 5 Trending Stocks: Prestige Wealth's IPO, Rivian's Lawsuit, Meta's New Platform, Tesla's Dip, And Biogen's FDA Approval
July 06, 2023
From Benzinga
From MarketWatch
From InvestorPlace
Biogen Reports New Spinraza Data In Atrophy Patients After Incomplete Response To Novartis' Treatment
July 03, 2023
From Benzinga
From Benzinga
Tickers
BIIB
From Motley Fool
Alleged Industrial Espionage Makes an Interesting Story
June 21, 2023
From Motley Fool
From Benzinga
Tickers
BIIB
From Motley Fool
How to Retire Rich: Biotech Stocks Edition
June 18, 2023
From InvestorPlace
2 Market-Beating Stocks With Major Catalysts on the Way
June 17, 2023
From Motley Fool
7 Undervalued S&P 500 Stocks to Buy in June
June 15, 2023
From InvestorPlace
Senator Bernie Sanders Puts Brakes on Health Agency Nominees Until Drug Pricing Issue is Addressed
June 14, 2023
From Benzinga
Methode Electronics, Brookfield Renewable Partners And Other Big Stocks Moving Lower On Tuesday
June 13, 2023
From Benzinga
From Benzinga
Alzheimer's Drug Leqembi Faces Hurdles in Europe: Concerns Over Health Risks and Healthcare Resources
June 13, 2023
From Benzinga
Prospects for Full Approval of Eisai and Biogen's Leqembi Shine Brighter after FDA Committee Vote
June 12, 2023
From Benzinga
Why Are Cruise Stocks CCL, RCL, NCLH Up Today?
June 12, 2023
From InvestorPlace
From InvestorPlace
From Benzinga
Goldman pushes back against bearish Morgan Stanley’s Mike Wilson with new 4,500 S&P 500 target
June 12, 2023
From MarketWatch
Biogen stock climbs on drug approval recommendation, Oracle shares rise ahead of earnings, and other stocks on the move
June 12, 2023
From MarketWatch
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.